1429199-83-6

Basic information

• Product Name: (7S,8aR)-2-benzyloctahydropyrrolo[1,2-a]pyrazin-7-ol
• Synonyms: (7S,8aR)-2-benzyloctahydropyrrolo[1,2-a]pyrazin-7-ol
• CAS NO: 1429199-83-6
• Molecular Weight: 232.326
• Mol File: 1429199-83-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (7S,8aR)-2-benzyloctahydropyrrolo[1,2-a]pyrazin-7-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (7S,8aR)-2-benzyloctahydropyrrolo[1,2-a]pyrazin-7-ol(1429199-83-6)
• EPA Substance Registry System: (7S,8aR)-2-benzyloctahydropyrrolo[1,2-a]pyrazin-7-ol(1429199-83-6)

Safety Data

• Hazardous Substances Data: 1429199-83-6(Hazardous Substances Data)

Upstream product

• 142347-81-7 (2R,4S)-4-hydroxypyrrolidine-2-carboxylic acid hydrochloride 
• 481704-21-6 (2R,4S)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride 
• 1429199-82-5 (7S,8aR)-2-benzyl-7-hydroxyhexahydropyrrolo[1,2-a]pyrazine-1,4-dione 
• 1429199-81-4 (2R,4S)-methyl 1-(2-chloroacetyl)-4-hydroxypyrrolidine-2-carboxylate 
• 100-46-9 benzylamine 

Downstream Products

• 1429200-47-4 (7S,8aR)-octahydropyrrolo[1,2-a]pyrazin-7-ol 
• 1429196-79-1 (7S,8aR)-7-[(5-cyclopropylpyrazin-2-yl)oxy]-2-{[3-(trifluoromethyl)phenyl]-sulfonyl}octahydropyrrolo[1,2-a]pyrazine 
• 1429196-78-0 (7S,8aR)-2-{[3-(trifluoromethyl)phenyl]sulfonyl}octahydropyrrolo[1,2-a]-pyrazin-7-ol 
• 1429199-26-7 (7S,8aR)-2-{[4-(trifluoromethyl)phenyl]sulfonyl}octahydropyrrolo[1,2-a]-pyrazin-7-ol 
• 1429197-85-2 (7R,8aR)-7-[(5-cyclopropylpyrazin-2-yl)oxy]-2-{[3-(trifluoromethyl)phenyl]-sulfonyl}octahydropyrrolo[1,2-a]pyrazine 

Relevant articles and documents

PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS

Compounds of Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V), Formula (VI), Formula (VII), Formula (VIII), and methods of use as lnterleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS

The present application relates to: (a) compounds of Formula (I): (I), and salts thereof, wherein Z1, Z2, Z3, Z4, R1, R2, and R3 are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use as calcium channel inhibitors.